Arteriosclerosis and Thrombosis, Vol 13, 669-674, Copyright © 1993 by American Heart Association
ARTICLES |
BA Konkle, PK Schick, X He, RJ Liu and EM Mazur
Cardeza Foundation for Hematologic Research, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107.
Plasminogen activator inhibitor-1 (PAI-1) is present in the platelet alpha-granule and is released on platelet activation. Platelet PAI-1 could either be synthesized by the megakaryocyte or taken up from the plasma. In this report we confirm the presence of PAI-1 protein in human megakaryocytes by Western blot analysis and show its synthesis in guinea pig megakaryocytes by metabolic labeling. We document the presence of PAI-1 mRNA in human platelets and show a 3-kb mRNA species on Northern blot analysis of guinea pig megakaryocytes. Neither untreated CHRF-288 cells, a megakaryoblastic cell line, nor human erythroleukemia (HEL) cells expressed PAI-1 mRNA. Phorbol ester (phorbol 12-myristate 13-acetate, 160 nM) treatment of CHRF-288 and HEL cells for 4 days induced PAI-1 mRNA expression in CHRF-288 cells but not in HEL cells. These studies show that PAI-1 is synthesized by megakaryocytes. Megakaryocytes most likely determine the PAI-1 content of platelets and thereby establish the antifibrinolytic potential of the platelet.
This article has been cited by other articles:
![]() |
A. Birdane, I. C. Haznedaroglu, N. Bavbek, A. Kosar, Y. Buyukasik, O. Ozcebe, S. V. Dundar, and S. Kirazli The Plasma Levels of Prostanoids and Plasminogen Activator Inhibitor-1 in Primary and Secondary Thrombocytosis Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 197 - 201. [Abstract] [PDF] |
||||
![]() |
J. P. McRedmond, S. D. Park, D. F. Reilly, J. A. Coppinger, P. B. Maguire, D. C. Shields, and D. J. Fitzgerald Integration of Proteomics and Genomics in Platelets: A PROFILE OF PLATELET PROTEINS AND PLATELET-SPECIFIC GENES Mol. Cell. Proteomics, February 1, 2004; 3(2): 133 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Madoiwa, N. Komatsu, J. Mimuro, K. Kimura, M. Matsuda, and Y. Sakata Developmental Expression of Plasminogen Activator Inhibitor-1 Associated With Thrombopoietin-Dependent Megakaryocytic Differentiation Blood, July 15, 1999; 94(2): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Lang, T. L. Chuang, C. F. Barbas III, and R. R. Schleef Purification of Storage Granule Protein-23. A NOVEL PROTEIN IDENTIFIED BY PHAGE DISPLAY TECHNOLOGY AND INTERACTION WITH TYPE I PLASMINOGEN ACTIVATOR INHIBITOR J. Biol. Chem., November 22, 1996; 271(47): 30126 - 30135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Riewald, K. A. Morgenstern, and R. R. Schleef Identification and Characterization of the Cytoplasmic Antiproteinase (CAP) in Human Platelets J. Biol. Chem., March 22, 1996; 271(12): 7160 - 7167. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Lang and R. R. Schleef Calcium-dependent Stabilization of Type I Plasminogen Activator Inhibitor within Platelet alpha-Granules J. Biol. Chem., February 2, 1996; 271(5): 2754 - 2761. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |